Detection of procoagulant imbalance Modified endogenous thrombin potential with results expressed as ratio of values with-to-without thrombomodulin

被引:39
作者
Tripodi, Armando [1 ,2 ]
机构
[1] Univ Milan, Dept Clin Sci & Community Hlth, Angelo Bianchi Bonomi Hemophilia & Thrombosis Ctr, Milan, Italy
[2] IRCCS Ca Granda Maggiore Hosp Fdn, Milan, Italy
关键词
Hypercoagulability; thrombosis; protein C/S pathway; factor VIII; ACTIVATED PROTEIN-C; FATTY LIVER-DISEASE; 3RD-GENERATION ORAL-CONTRACEPTIVES; CONVENTIONAL COAGULATION TESTS; ACQUIRED APC RESISTANCE; RANDOMIZED CROSS-OVER; V-LEIDEN MUTATION; VENOUS THROMBOEMBOLISM; FACTOR-VIII; HORMONAL CONTRACEPTION;
D O I
10.1160/TH16-10-0806
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Each individual possesses his/her own endogenous-thrombin-potential (ETP) (i.e. the ability to generate thrombin) which depends on the relative strength of the pro- and anticoagulant drivers operating in plasma. This ability depends in turn on the clinical conditions in which the balance between the two drivers is variably affected. One of the major determinants of this balance is the factor (F)VIII-protein C(PC) axis and its effect can be conveniently explored by the thrombin generation procedures with results expressed as ETP ratio with/without thrombomodulin (TM) (ETP-TM ratio). Furthermore, owing to the many feedback mechanisms mediated by thrombin (e.g. activation of PC, FXI, FV, FVIII, platelets etc.) it is also possible that any perturbation of the balance between pro- and anticoagulants that may occur in plasma even outside the FVIII-PC axis could result in an increased ETP-TM ratio and therefore may suggest a procoagulant imbalance. Indeed, other non-coagulation moieties (e.g. microparticles, neutrophil extracellular traps, pro-inflammatory cytokines and others) circulating in blood of patients with various clinical conditions may also contribute to the procoagulant imbalance even when FVIII and/or PC are apparently normal. It can be postulated that dual ETP measurements performed in the presence and absence of TM with results expressed as their ratio may be the candidate procedure to detect subtle procoagulant imbalance in many clinical conditions characterised by an increased risk of thromboembolism. This article aimed at reviewing the clinical conditions in which evidence for the value of the ETP-TM ratio has been provided.
引用
收藏
页码:830 / 836
页数:7
相关论文
共 71 条
[1]   Procoagulant effect of vitamin K antagonists? [J].
Al Dieri, R. ;
Ten Cate-Hoek, A. ;
Bloemen, S. ;
Ten Cate, H. ;
Hemker, H. C. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (12) :2511-2512
[2]   Extracellular histones increase plasma thrombin generation by impairing thrombomodulin-dependent protein C activation [J].
Ammollo, C. T. ;
Semeraro, F. ;
Xu, J. ;
Esmon, N. L. ;
Esmon, C. T. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (09) :1795-1803
[3]   Anti-protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome [J].
Arachchillage, D. R. J. ;
Efthymiou, M. ;
Mackie, I. J. ;
Lawrie, A. S. ;
Machin, S. J. ;
Cohen, H. .
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (11) :1801-1809
[4]   Elevated Levels of Circulating DNA and Chromatin Are Independently Associated With Severe Coronary Atherosclerosis and a Prothrombotic State [J].
Borissoff, Julian I. ;
Joosen, Ivo A. ;
Versteylen, Mathijs O. ;
Brill, Alexander ;
Fuchs, Tobias A. ;
Savchenko, Alexander S. ;
Gallant, Maureen ;
Martinod, Kimberly ;
ten Cate, Hugo ;
Hofstra, Leonard ;
Crijns, Harry J. ;
Wagner, Denisa D. ;
Kietselaer, Bas L. J. H. .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (08) :2032-2040
[5]   Regulation of coagulation by protein S [J].
Castoldi, Elisabetta ;
Hackeng, Tilman M. .
CURRENT OPINION IN HEMATOLOGY, 2008, 15 (05) :529-536
[6]  
Chantarangkul V, 2003, HAEMATOLOGICA, V88, P547
[7]   Inhibition of Intrinsic Xase by Protein S A Novel Regulatory Role of Protein S Independent of Activated Protein C [J].
Chattopadhyay, Rima ;
Sengupta, Tanusree ;
Majumder, Rinku .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2012, 32 (10) :2387-+
[8]  
Curvers J, 1999, BRIT J HAEMATOL, V105, P88, DOI 10.1046/j.1365-2141.1999.01302.x
[9]   Progress in the understanding of the protein C anticoagulant pathway [J].
Dahlbäck, B .
INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (02) :109-116
[10]   Advances in understanding pathogenic mechanisms of thrombophilic disorders [J].
Dahlback, Bjorn .
BLOOD, 2008, 112 (01) :19-27